Measurement of plasma-derived substance P: Biological, methodological, and statistical considerations

被引:23
作者
Campbell, Donald E.
Raftery, Nancy
Tustin, Richard
Tustin, Nanc B., III
DeSilvio, Michelle L.
Cnaan, Avital
Aye, Pyone Pyone
Lackner, Andrew A.
Douglas, Steven D.
机构
[1] Childrens Hosp Philadelphia, Div Allergy & Immunol, Philadelphia, PA 19104 USA
[2] Childrens Hosp Philadelphia, Div Biostat & Epidemiol, Philadelphia, PA 19104 USA
[3] Childrens Hosp Philadelphia, Joseph Stokes Jr Res Inst, Philadelphia, PA 19104 USA
[4] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA
[5] Tulane Natl Primate Res Ctr, Covington, LA USA
关键词
D O I
10.1128/CVI.00174-06
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The undecapeptide substance P (SP) is a member of the tachykinin family of neurotransmitters, which has a pivotal role in the regulation of inflammatory and immune responses. One of the major barriers to the study of the in vivo role of SP in a number of immune disorders is the accurate measurement of SP in fluids. This is reflected in the variability of reported SP levels in serum and plasma of humans in both healthy and diseased states. This study was initiated in order to identify sources of variability by the comparative evaluation of the influences of sample preparation and analytical detection methods on the measurement of SP in plasma. The results indicate that sample preparation (peptide extraction versus no extraction) and the choice of analytical method for SP quantitation may yield significantly different values and may contribute to the variability in SP values reported in the literature. These results further emphasize the need for careful consideration in the selection of methods for SP quantitation, as well as caution in the interpretation and comparison of data reported in the literature.
引用
收藏
页码:1197 / 1203
页数:7
相关论文
共 40 条
[1]  
Anichini M, 1997, REV RHUM, V64, P18
[2]   Applying the right statistics: analyses of measurement studies [J].
Bland, JM ;
Altman, DG .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2003, 22 (01) :85-93
[3]   STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT [J].
BLAND, JM ;
ALTMAN, DG .
LANCET, 1986, 1 (8476) :307-310
[4]   Substance P serum levels are increased in major depression:: Preliminary results [J].
Bondy, B ;
Baghai, TC ;
Minov, C ;
Schüle, C ;
Schwarz, MJ ;
Zwanzger, P ;
Rupprecht, R ;
Möller, HJ .
BIOLOGICAL PSYCHIATRY, 2003, 53 (06) :538-542
[5]   Tachykinin-mediated modulation of the immune response [J].
Bost, KL .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2004, 9 :3331-3332
[6]   Neurogenic amplification of immune complex inflammation [J].
Bozic, CR ;
Lu, B ;
Hopken, UE ;
Gerard, C ;
Gerard, NP .
SCIENCE, 1996, 273 (5282) :1722-1725
[7]   PLASMA SUBSTANCE-P LEVELS IN NORMOTENSIVE AND HYPERTENSIVE SUBJECTS [J].
CAMPBELL, WB ;
HOLLAND, OB ;
GOMEZSANCHEZ, CE ;
GRAHAM, RM ;
PETTINGER, WA ;
WHITE, AC .
CLINICAL AND EXPERIMENTAL HYPERTENSION, 1981, 3 (02) :183-193
[8]   AMINO-ACID SEQUENCE OF SUBSTANCE P [J].
CHANG, MM ;
LEEMAN, SE ;
NIALL, HD .
NATURE-NEW BIOLOGY, 1971, 232 (29) :86-+
[9]   SUBSTANCE-P - CORRELATION OF CSF AND PLASMA-LEVELS [J].
CLARK, JW ;
SENANAYAKE, PD ;
SOLOMON, GD ;
GALLAGHER, C .
HEADACHE, 1994, 34 (05) :261-264
[10]   THE BINDING OF ENDOGENOUS AND EXOGENOUS SUBSTANCE-P IN HUMAN PLASMA [J].
CORBALLY, N ;
POWELL, D ;
TIPTON, KF .
BIOCHEMICAL PHARMACOLOGY, 1990, 39 (07) :1161-1166